Hutch News

Hutch News

Stories tagged 'Infectious Diseases'

Open Science Prize goes to software tool for tracking viral outbreaks

Nextstrain wins international competition by making it easier to share, analyze genetic-sequencing data of spreading viruses

Feb. 28, 2017 | By Mary Engel / Fred Hutch News Service

After three rounds of competition — one of which involved a public vote — a software tool developed by researchers at Fred Hutchinson Cancer Research Center and the University of Basel to track Zika, Ebola and other viral disease outbreaks in real time has won the first-ever international Open Science Prize.

View story >


Happy 10th 'birthday,' Timothy Ray Brown

A decade after the first and so far only known HIV cure, researchers are hard at work to find a cure for many more

Feb. 7, 2017 | By Mary Engel / Fred Hutch News Service

A decade after Timothy Ray Brown underwent a bone marrow transplant that made him the first person to be cured of HIV, scientists at Fred Hutch and other institutions are working hard to make sure he will not remain the only person cured.

View story >


A Q&A with Fred Hutch's Dr. Trevor Bedford

'Trying to be useful instead of trying to be clever': An evolutionary biologist-virologist-immunologist-computer-wonk finds his niche

Dec. 21, 2016 | By Mary Engel / Fred Hutch News Service

Fred Hutch's Dr. Trevor Bedford takes time away from figuring out how flu strains move around the world and wrangling Zika metadata to explain how he came to do what he does — and just what that entails.

View story >


'Roz and Ray': An HIV tragedy with lessons for today

Seattle Repertory drama, panel explore fallout from an early AIDS crisis in hemophiliacs

Nov. 3, 2016 | By Mary Engel / Fred Hutch News Service

A Seattle Repertory drama and a panel of physician-scientists and activists from Fred Hutch, SCCA and the Bleeding Disorder Foundation of Washington explore the fallout from an early AIDS crisis in hemophiliacs.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Oct. 27, 2016

Good News: Halloran honored in Rome; Hutch nominated for nonprofit of the year; Obliteride amassed $2.4M.

View story >


HIV prevention gains bring hope — and challenges

Injectable PrEP and other options are in the pipeline, and that makes clinical trials more complicated

Oct. 14, 2016 | By Mary Engel / Fred Hutch News Service

An injectable form of PrEP and other options are in the pipeline as the HIV field enters a new era of prevention. But such advances, as welcome as they are, come with a twist: They complicate the task of designing the clinical trials needed to test additional tools. Fred Hutch's Dr. Deborah Donnell explains.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.